LLY

730.78

-2.48%↓

JNJ

153.66

-0.07%↓

ABBV

181.97

-1.36%↓

NVO

68.44

+0.16%↑

UNH

303.51

-5.74%↓

LLY

730.78

-2.48%↓

JNJ

153.66

-0.07%↓

ABBV

181.97

-1.36%↓

NVO

68.44

+0.16%↑

UNH

303.51

-5.74%↓

LLY

730.78

-2.48%↓

JNJ

153.66

-0.07%↓

ABBV

181.97

-1.36%↓

NVO

68.44

+0.16%↑

UNH

303.51

-5.74%↓

LLY

730.78

-2.48%↓

JNJ

153.66

-0.07%↓

ABBV

181.97

-1.36%↓

NVO

68.44

+0.16%↑

UNH

303.51

-5.74%↓

LLY

730.78

-2.48%↓

JNJ

153.66

-0.07%↓

ABBV

181.97

-1.36%↓

NVO

68.44

+0.16%↑

UNH

303.51

-5.74%↓

Search

STAAR Surgical Co

Open

BrancheGesundheitswesen

18.82 -2.54

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

18.63

Max

19.51

Schlüsselkennzahlen

By Trading Economics

Einkommen

-20M

-54M

Verkäufe

-6.4M

43M

KGV

Branchendurchschnitt

55.443

54.533

EPS

-1.005

Gewinnspanne

-127.289

Angestellte

1,157

EBITDA

-43M

-71M

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

-0.52% downside

Dividenden

By Dow Jones

Nächstes Ergebnis

6. Aug. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

160M

953M

Vorheriger Eröffnungskurs

21.36

Vorheriger Schlusskurs

18.82

Nachrichtenstimmung

By Acuity

50%

50%

179 / 382 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bullish Evidence

STAAR Surgical Co Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

20. Mai 2025, 20:54 UTC

Akquisitionen, Fusionen, Übernahmen

PNC to Buy Private-Equity Agent Aqueduct Capital

20. Mai 2025, 20:50 UTC

Ergebnisse

Palo Alto Networks Posts Higher 3Q Sales, Profit Slips

20. Mai 2025, 23:48 UTC

Akquisitionen, Fusionen, Übernahmen

Kraft Heinz Evaluating Strategic Transactions, Berkshire Hathaway Steps Away From Board -- Update

20. Mai 2025, 23:42 UTC

Market Talk

Nikkei May Trade Rangebound Amid Tariff Uncertainty -- Market Talk

20. Mai 2025, 23:39 UTC

Market Talk

Gold Steady, Supported by Lingering U.S. Fiscal-Deficit Concerns -- Market Talk

20. Mai 2025, 23:08 UTC

Market Talk

James Hardie's Repair & Remodel Outlook Surprises RBC -- Market Talk

20. Mai 2025, 22:46 UTC

Akquisitionen, Fusionen, Übernahmen

Gold Road: Takeover Remains Subject to Independent Expert Findings; Shareholder, Court Approval

20. Mai 2025, 22:45 UTC

Akquisitionen, Fusionen, Übernahmen

Gold Road: Notified Australia Government Has No Objections to Takeover by Gold Fields

20. Mai 2025, 22:44 UTC

Top News

Venezuela Frees U.S. Air Force Veteran in Overture to Trump -- 2nd Update

20. Mai 2025, 22:20 UTC

Top News

In Latest EV Pullback, Ford to Share Battery Plant With Nissan -- WSJ

20. Mai 2025, 22:00 UTC

Ergebnisse

ZTO Express (Cayman) 1Q Adj EPS 37c >ZTO

20. Mai 2025, 22:00 UTC

Ergebnisse

ZTO Express (Cayman) 1Q EPS 34c >ZTO

20. Mai 2025, 22:00 UTC

Ergebnisse

ZTO Express (Cayman) 1Q Rev $1.5B >ZTO

20. Mai 2025, 21:44 UTC

Ergebnisse

James Hardie Industries 4Q Adj EPS 36c >JHX

20. Mai 2025, 21:44 UTC

Ergebnisse

James Hardie Industries: Sees FY26 North America Net Sales Growth Up Low Single Digits >JHX

20. Mai 2025, 21:44 UTC

Ergebnisse

James Hardie Industries 4Q EPS 10c >JHX

20. Mai 2025, 21:44 UTC

Ergebnisse

James Hardie Industries 4Q Sales $972M >JHX

20. Mai 2025, 20:52 UTC

Top News

Elon Musk to Cut Back Political Spending -- 3rd Update

20. Mai 2025, 20:52 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

20. Mai 2025, 20:52 UTC

Market Talk

Mexican Stocks Near Record High As Trade Concerns Ease -- Market Talk

20. Mai 2025, 20:30 UTC

Akquisitionen, Fusionen, Übernahmen

PNC Financial: Aqueduct Acquisition Expected to Close in Mid-Summer, Terms Won't be Disclosed >PNC

20. Mai 2025, 20:28 UTC

Akquisitionen, Fusionen, Übernahmen

PNC Bank Agrees To Acquire Aqueduct Capital Group To Complement Harris Williams Capabilities >PNC

20. Mai 2025, 20:23 UTC

Akquisitionen, Fusionen, Übernahmen

Tesla CEO Musk Says He Plans to Be at White House for a Couple Days Every Few Weeks

20. Mai 2025, 20:22 UTC

Ergebnisse

XP 1Q Adj EPS BRL2.29 >XP

20. Mai 2025, 20:22 UTC

Ergebnisse

XP 1Q Rev BRL4.345B >XP

20. Mai 2025, 20:21 UTC

Akquisitionen, Fusionen, Übernahmen

Tesla CEO Musk: 'We're in the Big Bang of Intelligence Explosion'

20. Mai 2025, 20:20 UTC

Top News

Fed's Bostic Signals Longer Delay in Cutting Interest Rates -- Barrons.com

20. Mai 2025, 20:19 UTC

Akquisitionen, Fusionen, Übernahmen

Tesla CEO Musk Says He Doesn't Currently Have Plans to Merge Tesla, xAI

20. Mai 2025, 20:11 UTC

Top News

Venezuela Frees U.S. Air Force Veteran in Overture to Trump -- Update

20. Mai 2025, 20:09 UTC

Ergebnisse

Palo Alto Networks 3Q Remaining Performance Obligation $13.5 B >PANW

Peer-Vergleich

Kursveränderung

STAAR Surgical Co Prognose

Kursziel

By TipRanks

-0.52% Nachteil

12-Monats-Prognose

Durchschnitt 19.14 USD  -0.52%

Hoch 27 USD

Tief 13 USD

Basierend auf 10 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für STAAR Surgical Co – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

10 ratings

2

Buy

7

Halten

1

Sell

Technischer Score

By Trading Central

18.604 / 20.07Unterstützung & Widerstand

Kurzfristig

Strong Bullish Evidence

Mittelfristig

Very Strong Bullish Evidence

Langfristig

No Evidence

Stimmung

By Acuity

179 / 382 Ranking in Gesundheitswesen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über STAAR Surgical Co

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.